Two SNPs in the promoter region of the CTLA-4 gene affect binding of transcription factors and are associated with human myasthenia gravis
about
CTLA4 variants and haplotype contribute genetic susceptibility to myasthenia gravis in northern Chinese population.Pretreatment Predictors of Response to PegIFN-RBV Therapy in Egyptian Patients with HCV Genotype 4.Complicating autoimmune diseases in myasthenia gravis: a review.A genome-wide association study of myasthenia gravisMyasthenia Gravis Induced by Ipilimumab in Patients With Metastatic MelanomaEffect of CTLA-4 gene polymorphisms on long-term kidney allograft function in Han Chinese recipients.The Cytotoxic T Lymphocyte Antigen-4 +49A/G Single Nucleotide Polymorphism Association With Visceral Leishmaniasis.Transcriptional control of the human glucocorticoid receptor: identification and analysis of alternative promoter regions.Lack of association between sCTLA-4 levels in human plasma and common CTLA-4 polymorphisms.Recent advances in genetic predisposition of myasthenia gravis.Detecting key genes regulated by miRNAs in dysfunctional crosstalk pathway of myasthenia gravis.A Sensitive Method for Detecting Peptide-specific CD4+ T Cell Responses in Peripheral Blood from Patients with Myasthenia Gravis.Familial aggregation of myasthenia gravis in affected families: a population-based study.Juvenile-onset myasthenia gravis: autoantibody status, clinical characteristics and genetic polymorphisms.Gene Polymorphisms for Both Auto-antigen and Immune-Modulating Proteins Are Associated with the Susceptibility of Autoimmune Myasthenia Gravis.Association of CTLA-4 gene polymorphisms with sporadic breast cancer risk and clinical features in Han women of northeast China.Association of cytotoxic T lymphocyte associated antigen-4 gene (rs60872763) polymorphism with Crohn's disease and high levels of serum sCTLA-4 in Crohn's disease.Circulating soluble CTLA4 (sCTLA4) is elevated in patients with breast cancer
P2860
Q33864254-64FCBFF7-047D-40A6-A3E1-A7AE05C17602Q35995923-17A9156F-AC6D-40A3-8DF5-0867221ED9C6Q36192435-B10721A6-E5A6-4DA5-9EC1-53DAAB4B69C8Q36869250-029ABC9B-DFB1-4D43-94DF-840BDD4ABE01Q37163559-65923629-7476-457B-B645-5CA350006D5CQ37268950-8BEACCFE-6014-4BEB-A360-739079D8EB47Q39041628-B0AA97D1-4E8F-4748-9142-DA41E8566A7CQ39607960-53A9D0D3-DBB8-4277-B859-546492BAB544Q41191163-46F9A56E-20B7-4045-A9CF-924CC80FE47FQ41953614-FB6EAF10-9CF5-43DA-BCC5-5DC4C9E59A49Q43150803-F84E3839-7E58-487E-8CAB-211E50C81EB2Q46908307-354527D5-CEAC-4873-9CCC-4CF406266270Q47120889-7E081773-2B88-4BC5-92EB-EC336D3FE762Q48339804-CD165BD0-069F-4294-80AB-C3EA07EBDE88Q51584920-E8138C41-78BD-4F7C-BF5E-7119DFE6FF3DQ54328968-6933BF87-DA49-471F-8AB5-59700B829241Q54391869-A24E0F26-2CF0-4734-A827-7A995C24BE04Q56899352-BEBAB6B2-5B76-4697-A09E-0476EB245942
P2860
Two SNPs in the promoter region of the CTLA-4 gene affect binding of transcription factors and are associated with human myasthenia gravis
description
article
@en
im Januar 2008 veröffentlichter wissenschaftlicher Artikel
@de
wetenschappelijk artikel
@nl
наукова стаття, опублікована в січні 2008
@uk
name
Two SNPs in the promoter regio ...... d with human myasthenia gravis
@en
Two SNPs in the promoter regio ...... d with human myasthenia gravis
@nl
type
label
Two SNPs in the promoter regio ...... d with human myasthenia gravis
@en
Two SNPs in the promoter regio ...... d with human myasthenia gravis
@nl
prefLabel
Two SNPs in the promoter regio ...... d with human myasthenia gravis
@en
Two SNPs in the promoter regio ...... d with human myasthenia gravis
@nl
P2093
P2860
P1476
Two SNPs in the promoter regio ...... d with human myasthenia gravis
@en
P2093
A K Lefvert
R Giscombe
R Pirskanen
P2860
P356
10.1111/J.1365-2796.2007.01879.X
P407
P577
2008-01-01T00:00:00Z